Page last updated: 2024-10-28

hydroxyurea and Atrial Septal Defect

hydroxyurea has been researched along with Atrial Septal Defect in 1 studies

Research Excerpts

ExcerptRelevanceReference
" In this short communication, we describe a woman with sickle cell anemia responsive to hydroxyurea (HU) therapy who had primary stroke due to paradoxical embolization caused by a large atrial septal defect."7.80Primary stroke in a woman with sickle cell anemia responsive to hydroxyurea therapy. ( Ballas, SK; Martinez, U; Savage, M, 2014)
" In this short communication, we describe a woman with sickle cell anemia responsive to hydroxyurea (HU) therapy who had primary stroke due to paradoxical embolization caused by a large atrial septal defect."3.80Primary stroke in a woman with sickle cell anemia responsive to hydroxyurea therapy. ( Ballas, SK; Martinez, U; Savage, M, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ballas, SK1
Martinez, U1
Savage, M1

Other Studies

1 other study available for hydroxyurea and Atrial Septal Defect

ArticleYear
Primary stroke in a woman with sickle cell anemia responsive to hydroxyurea therapy.
    Hemoglobin, 2014, Volume: 38, Issue:5

    Topics: Adult; Anemia, Sickle Cell; Antisickling Agents; Brain Ischemia; Echocardiography, Transesophageal;

2014